Developing a new imaging technique for breast cancer detection
A Single-Sided Magnetic Particle Imaging Scanner for In Vivo Breast Cancer Imaging
['FUNDING_R15'] · OAKLAND UNIVERSITY · NIH-10874920
This study is testing a new type of imaging machine that can take clear pictures of breast cancer without using harmful radiation, making it safer for both people and small animals.
Quick facts
| Phase | ['FUNDING_R15'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | OAKLAND UNIVERSITY (nih funded) |
| Locations | 1 site (ROCHESTER, UNITED STATES) |
| Trial ID | NIH-10874920 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a specialized Magnetic Particle Imager (MPI) that can provide non-invasive imaging for breast cancer without using harmful radiation or toxic substances. The innovative design features a single-sided scanner that can be used for both small animals and humans, allowing for detailed imaging of cancerous tissues. By utilizing a unique field-free line geometry, this approach aims to enhance image quality and resolution significantly. The ultimate goal is to demonstrate the effectiveness of this technology in imaging breast cancer in live subjects.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with breast cancer who require advanced imaging techniques for better diagnosis and treatment planning.
Not a fit: Patients who do not have breast cancer or those who are not eligible for imaging studies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective imaging techniques for breast cancer diagnosis.
How similar studies have performed: While Magnetic Particle Imaging is a relatively novel approach, preliminary studies have shown promise in similar imaging techniques, indicating potential for success.
Where this research is happening
ROCHESTER, UNITED STATES
- OAKLAND UNIVERSITY — ROCHESTER, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TONYUSHKIN, ALEXEY A — OAKLAND UNIVERSITY
- Study coordinator: TONYUSHKIN, ALEXEY A
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Breast Cancer, Disorder